A case of severe adult botulism with paralysis, respiratory failure and cranial nerve palsies is presented. The pathophysiology, clinical manifestations, diagnosis and treatment options for botulism are discussed.
CASE HISTORY
A 62-year-old man with a past medical history of hypertension, high alcohol intake and transient ischaemic attacks was found collapsed, with difficulty breathing. He had been unwell for several days, with sore throat and fevers. On admission to hospital he was diaphoretic and dyspnoeic with normal pulse and blood pressure. Closer examination revealed dysarthria, left facial weakness, equal pupils, hyporeflexia and bilateral reduced muscle power. Hypoventilation and hypoxia progressed. He was sedated, intubated and mechanical ventilation was commenced. The presumed diagnosis was a brainstem stroke and he was transferred to a tertiary hospital.
After arrival at Liverpool Hospital, sedation was ceased. Examination revealed that he was able to obey commands but only had movement of his lower arms and toes. Pupils were 3 mm and reactive. Third, fourth, fifth and sixth cranial nerve function was absent and there was a left facial weakness. Gag and cough reflexes were absent and there was generalized limb weakness, hypotonia and areflexia.
A cerebral CT scan on admission was normal and when repeated the following day, remained unchanged. Serum electrolytes, glucose and blood count were normal, the ESR was 69 mm/h and cerebrospinal fluid examination was normal. Urine was negative for porphobilinogen and the faecal porphyrin level was normal. Pseudocholinesterase level was 6346U/l (normal range 3500 to 8500 U/l). Acetylcholine antibody testing was negative. Cerebral angiography on day 2 demonstrated narrowing of the left anterior and inferior cerebellar artery, but an MRI showed no evidence of a brainstem cerebrovascular event and no evidence of changes associated with multiple sclerosis. Plain abdominal radiographs revealed gaseous distension of large and small bowel with multiple fluid levels.
Nerve conduction studies showed low amplitude compound muscle action potential (CMAP) responses with normal conduction in motor nerves. Sensory studies were within normal limits. An EEG performed early was reported as being abnormal and suggestive of upper brainstem dysfunction.
Serum sent for botulism mouse inoculation testing on day 2 was reported positive for type E Clostridium botulinum toxin.
A tracheostomy and feeding jejunostomy was performed on day 12 and a nosocomial pneumonia was treated with antibiotics. He gradually regained strength but remained in the Intensive Care Unit for 35 days. He was subsequently transferred for rehabilitation and then discharged home. A health inspector established that the patient had eaten reheated cold chicken several days prior to his admission to hospital.
DISCUSSION
Clostridium botulinum is an anaerobic, grampositive, spore-forming bacillus, which is found in soil throughout the world. The bacterial spores are heat resistant and are able to survive food preservation 1 . The organism produces neurotoxins of which seven have been described 2,3 : however, most cases of human botulism are caused by types A, B or E. Type A toxin is found in preserved foods that are not heated to the correct temperature or maintained at this temperature for an adequate period of time. Home preserved and canned foods containing vegetables, fish and meat are recognised sources. Type E toxin is often associated with the ingestion of contaminated seafood but can occur in other foods 4 . The neurotoxin, whether produced in the intestine or ingested preformed, enters the vascular system and is transported to peripheral cholinergic nerve terminals. These include neuromuscular junctions, postganglionic parasympathetic nerve endings and peripheral ganglia. The central nervous system is rarely involved. The neurotoxin binds irreversibly to the presynaptic nerve ending and prevents the release of acetylcholine by enzymatically cleaving the protein required for docking of neurosecretory granules with the presynaptic membrane 5, 6 .
Five forms of botulism are described. Foodborne botulism occurs after ingestion of C. botulinum contaminated food containing the preformed neurotoxin. Infant botulism occurs when spores of C. botulinum are ingested and germinate in the intestinal tract and is the most frequently reported form of botulism 7 . The immature intestinal tract lacks the protective bacterial flora, allowing colonization by the toxinproducing organism. Honey has been implicated as a risk factor for infant botulism [7] [8] [9] . Wound botulism occurs in wounds contaminated with C. botulinum spores and an increasing number of wound botulism cases has recently been linked to the use of black tar heroin in the USA 10, 11 . Adult infectious botulism is also the result of intestinal colonization with C. botulinum, often occurring in patients who have a history of gastrointestinal abnormalities or recent antibiotic use 12, 13 . Inadvertent botulism has been described in patients being treated with botulinum toxin 14, 15 .
Foodborne botulism most frequently occurs in outbreaks, whereas other forms occur in sporadic cases. In the U.S.A., approximately 72% of reported botulism cases are infant botulism and 25% are foodborne botulism 16 . Botulism also has the potential to be used as an agent of biological warfare 17 .
One case of infantile botulism has been described in South Australia in 1998 18 .
In New South Wales, the laboratory will notify the Public Health Department when a sample is tested positive. Not all States in Australia will have similar notification procedures. National data is compiled from reported State data.
The initial symptoms of foodborne botulism are gastrointestinal, including nausea, vomiting, abdominal cramps, diarrhoea and constipation. Blurred vision, diplopia, opthalmoplegia, dysarthria and dysphagia are early neurological features. The cranial nerve abnormalities are followed by a descending pattern of weakness, and in severe cases, respiratory muscle weakness. Autonomic nervous system dysfunction may manifest as constipation, gastric dilatation, urinary retention, dry mouth, reduced lacrimation, pupillary abnormalities, labile blood pressure and arrhythmias. Sensory disturbance, altered mental state and fever are typically absent in botulism. Patients with severe botulism may present with rapidly evolving weakness. Onset of symptoms is usually within two to 36 hours after ingestion of contaminated food. Type A toxin is associated with more severe disease and a higher mortality rate than type B or E toxin 19 .
Infantile botulism usually affects children before the age of six months. Constipation followed by lethargy, poor feeding and loss of head control are typical features in this age group.The neurological features of wound botulism are similar to foodborne botulism.
Recovery from C. botulinum toxin poisoning is prolonged although usually complete, and probably correlates with the growth of new nerve terminals.
Botulism should be considered in any patient who is afebrile, mentally intact, and who has a descending paralysis with intact sensation. A possible list of differential diagnoses with discriminatory features is shown in Table 1 .
Diagnosis is confirmed by testing serum and stool for toxin or organism. In Australia, testing is performed in the Adelaide Women and Children's Hospital. The most reliable method for identification of C. botulinum toxin is the mouse inoculation test. Mice exposed and non-exposed to type specific botulism antitoxin are injected with patient serum. A positive test result is if the non-exposed mice die within 24 to 48 hours. The majority of results are available within 48 hours, the referring hospital is notified by phone immediately. Isolation of toxin from the serum, stool or the wound is diagnostic. Toxin is isolated in serum in 35% of cases. This decreases to less than 30% if the sample is collected more than two days after ingestion. Only 36% of stool cultures are positive after three days 21 . Electrophysiological tests can aid in the diagnosis. Nerve conduction studies demonstrate low amplitude CMAPs with normal conduction velocities and sensory nerve action potentials 22 .
Treatment is mainly supportive and because of the risk of rapid respiratory failure, patients suspected of having botulism should be cared for in an intensive care setting. Elective intubation and ventilation should be undertaken in those at risk of respiratory failure. Gastric lavage should be considered if recent contaminated food ingestion is suspected. Cathartic agents or enemas may also be considered for the removal of unabsorbed toxin in patients who do not have ileus 23 . Magnesium containing agents should be avoided because of the possible risk of potentiation of the action of the toxin at the nerve terminal. Antibiotics and surgical debridement of a wound suspected of being contaminated should be considered in wound botulism.
Specific therapy consists of antitoxin administration. This is an equine product with antibodies to Type A, B and E toxins. Beneficial effects are more likely with type E botulism, and to be of benefit, the antitoxin should be given early while the toxin is still in the blood. Serious side-effects may occur in more than 20% of patients 24 .
Overall mortality rates in botulism have fallen to less than 10 percent with improved supportive care. Mortality is higher above the age of 60 25 . Respiratory support may be required for months and weakness and autonomic dysfunction may persist for more than one year.
In summary we present a case of adult botulism as a potentially life-threatening but treatable cause of gastrointestinal disturbance, descending paralysis and respiratory failure. Awareness and prompt diagnosis, with improved supportive care improves survival. 
